 Hao Dun
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 4 | 2026 | 736 | 0.700 |
Why?
| | Tacrolimus | 3 | 2017 | 196 | 0.670 |
Why?
| | Transplantation, Heterotopic | 1 | 2020 | 16 | 0.650 |
Why?
| | Monocytes | 4 | 2025 | 538 | 0.630 |
Why?
| | Aorta, Abdominal | 1 | 2020 | 52 | 0.630 |
Why?
| | Graft Rejection | 5 | 2022 | 540 | 0.600 |
Why?
| | Kidney Transplantation | 6 | 2017 | 704 | 0.580 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2017 | 389 | 0.530 |
Why?
| | Immunosuppressive Agents | 4 | 2017 | 847 | 0.530 |
Why?
| | B-Lymphocytes | 2 | 2020 | 877 | 0.440 |
Why?
| | Macrophages | 4 | 2026 | 1511 | 0.410 |
Why?
| | Receptors, Immunologic | 5 | 2025 | 206 | 0.380 |
Why?
| | Receptors, CCR2 | 2 | 2025 | 39 | 0.380 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2017 | 917 | 0.320 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2017 | 1129 | 0.320 |
Why?
| | Macaca fascicularis | 8 | 2017 | 71 | 0.300 |
Why?
| | Graft Survival | 5 | 2026 | 526 | 0.270 |
Why?
| | Stromal Cells | 1 | 2026 | 125 | 0.230 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2025 | 7 | 0.230 |
Why?
| | Neutrophil Infiltration | 1 | 2025 | 104 | 0.220 |
Why?
| | Arginase | 1 | 2024 | 27 | 0.220 |
Why?
| | Coronary Vessels | 1 | 2026 | 251 | 0.210 |
Why?
| | Cell Communication | 1 | 2026 | 324 | 0.210 |
Why?
| | Animals | 22 | 2026 | 38109 | 0.190 |
Why?
| | Single-Cell Analysis | 1 | 2026 | 359 | 0.190 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2013 | 59 | 0.180 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 298 | 0.180 |
Why?
| | Myocardium | 3 | 2025 | 939 | 0.180 |
Why?
| | Mice, Inbred C57BL | 11 | 2026 | 5997 | 0.180 |
Why?
| | Membrane Glycoproteins | 1 | 2025 | 496 | 0.180 |
Why?
| | Mice | 13 | 2026 | 18365 | 0.180 |
Why?
| | Disease Models, Animal | 6 | 2026 | 4569 | 0.180 |
Why?
| | Mice, Inbred BALB C | 2 | 2022 | 1253 | 0.170 |
Why?
| | Phenprocoumon | 1 | 2020 | 4 | 0.160 |
Why?
| | Heart Injuries | 1 | 2020 | 42 | 0.150 |
Why?
| | Coronary Artery Disease | 1 | 2026 | 741 | 0.150 |
Why?
| | Transcriptome | 1 | 2026 | 1046 | 0.150 |
Why?
| | Drug Therapy, Combination | 3 | 2017 | 1048 | 0.150 |
Why?
| | Neutrophils | 1 | 2025 | 1134 | 0.150 |
Why?
| | Fatty Acids | 1 | 2022 | 452 | 0.140 |
Why?
| | Acute Lung Injury | 1 | 2022 | 303 | 0.140 |
Why?
| | Positron-Emission Tomography | 1 | 2020 | 343 | 0.140 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 326 | 0.140 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2017 | 13 | 0.130 |
Why?
| | Myocardial Infarction | 1 | 2024 | 1209 | 0.120 |
Why?
| | Allografts | 3 | 2026 | 150 | 0.120 |
Why?
| | Antibodies, Monoclonal | 2 | 2014 | 1524 | 0.120 |
Why?
| | Fingolimod Hydrochloride | 1 | 2017 | 39 | 0.120 |
Why?
| | Abatacept | 1 | 2016 | 56 | 0.120 |
Why?
| | CD40 Antigens | 2 | 2014 | 90 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2024 | 2050 | 0.120 |
Why?
| | Immunoconjugates | 1 | 2016 | 137 | 0.110 |
Why?
| | Immunologic Memory | 1 | 2017 | 366 | 0.110 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 866 | 0.100 |
Why?
| | Mycophenolic Acid | 1 | 2014 | 120 | 0.100 |
Why?
| | Reperfusion Injury | 2 | 2009 | 300 | 0.100 |
Why?
| | Chondrogenesis | 1 | 2013 | 88 | 0.090 |
Why?
| | Knee Injuries | 1 | 2013 | 122 | 0.090 |
Why?
| | Male | 15 | 2026 | 72406 | 0.090 |
Why?
| | Cartilage | 1 | 2013 | 198 | 0.080 |
Why?
| | Regeneration | 1 | 2013 | 197 | 0.080 |
Why?
| | Antilymphocyte Serum | 1 | 2010 | 61 | 0.080 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 598 | 0.080 |
Why?
| | Osteoarthritis | 1 | 2013 | 196 | 0.080 |
Why?
| | Urinary Incontinence | 1 | 2010 | 64 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2025 | 3125 | 0.080 |
Why?
| | Signal Transduction | 5 | 2026 | 5233 | 0.080 |
Why?
| | Ureteral Obstruction | 1 | 2010 | 62 | 0.070 |
Why?
| | Cartilage, Articular | 1 | 2013 | 343 | 0.070 |
Why?
| | Early Growth Response Protein 1 | 1 | 2009 | 32 | 0.070 |
Why?
| | Knee Joint | 1 | 2013 | 426 | 0.070 |
Why?
| | Sirolimus | 1 | 2010 | 281 | 0.070 |
Why?
| | Liver | 2 | 2009 | 1888 | 0.070 |
Why?
| | Skin | 1 | 2013 | 758 | 0.070 |
Why?
| | Interleukin-10 | 1 | 2009 | 310 | 0.060 |
Why?
| | T-Lymphocyte Subsets | 1 | 2009 | 415 | 0.060 |
Why?
| | Neointima | 1 | 2026 | 18 | 0.060 |
Why?
| | Receptor for Advanced Glycation End Products | 4 | 2009 | 31 | 0.060 |
Why?
| | Cell Lineage | 2 | 2024 | 376 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2006 | 509 | 0.060 |
Why?
| | Interferon Type I | 1 | 2026 | 145 | 0.060 |
Why?
| | Nitriles | 1 | 2026 | 205 | 0.050 |
Why?
| | Liver Regeneration | 1 | 2005 | 46 | 0.050 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2026 | 266 | 0.050 |
Why?
| | NF-kappa B | 2 | 2005 | 662 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2009 | 1217 | 0.050 |
Why?
| | Hepatitis | 1 | 2004 | 43 | 0.050 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2024 | 137 | 0.050 |
Why?
| | Cell Hypoxia | 1 | 2024 | 247 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2026 | 452 | 0.050 |
Why?
| | Ligands | 2 | 2022 | 674 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2020 | 1173 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2017 | 11695 | 0.050 |
Why?
| | Multiple Sclerosis | 1 | 2009 | 484 | 0.050 |
Why?
| | Reactive Oxygen Species | 1 | 2006 | 621 | 0.050 |
Why?
| | Liver Diseases | 1 | 2006 | 304 | 0.050 |
Why?
| | Pyrimidines | 1 | 2026 | 533 | 0.050 |
Why?
| | Ventricular Remodeling | 1 | 2024 | 276 | 0.050 |
Why?
| | Pyrazoles | 1 | 2026 | 510 | 0.050 |
Why?
| | Osteopontin | 1 | 2022 | 34 | 0.040 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2022 | 116 | 0.040 |
Why?
| | Survival Rate | 4 | 2010 | 2092 | 0.040 |
Why?
| | Humans | 9 | 2026 | 144957 | 0.040 |
Why?
| | Kidney | 2 | 2022 | 1496 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2010 | 80 | 0.040 |
Why?
| | Isotope Labeling | 1 | 2020 | 83 | 0.040 |
Why?
| | CD4 Antigens | 2 | 2010 | 139 | 0.040 |
Why?
| | Tissue Donors | 1 | 2022 | 424 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 322 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2020 | 320 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2022 | 1087 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2014 | 988 | 0.030 |
Why?
| | B7-2 Antigen | 1 | 2016 | 27 | 0.030 |
Why?
| | Kidney Function Tests | 1 | 2016 | 157 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3164 | 0.030 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2016 | 177 | 0.030 |
Why?
| | Female | 2 | 2022 | 78376 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 415 | 0.030 |
Why?
| | CD40 Ligand | 1 | 2014 | 40 | 0.030 |
Why?
| | Antigens, CD20 | 1 | 2014 | 35 | 0.030 |
Why?
| | Biotinylation | 1 | 2014 | 37 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 95 | 0.020 |
Why?
| | Collagenases | 1 | 2013 | 22 | 0.020 |
Why?
| | Cell Separation | 1 | 2014 | 307 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2016 | 760 | 0.020 |
Why?
| | Cytokines | 2 | 2014 | 2065 | 0.020 |
Why?
| | Clone Cells | 1 | 2013 | 266 | 0.020 |
Why?
| | Matrix Metalloproteinases | 1 | 2013 | 98 | 0.020 |
Why?
| | Creatinine | 1 | 2014 | 506 | 0.020 |
Why?
| | Joints | 1 | 2013 | 107 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 851 | 0.020 |
Why?
| | Isoantigens | 1 | 2010 | 17 | 0.020 |
Why?
| | Haplorhini | 1 | 2010 | 52 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2010 | 198 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 351 | 0.020 |
Why?
| | Drug Synergism | 1 | 2010 | 357 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1718 | 0.020 |
Why?
| | Random Allocation | 1 | 2010 | 363 | 0.020 |
Why?
| | P-Selectin | 1 | 2009 | 28 | 0.020 |
Why?
| | Chemokine CXCL2 | 1 | 2009 | 41 | 0.020 |
Why?
| | Self Tolerance | 1 | 2009 | 26 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2010 | 282 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 153 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 128 | 0.020 |
Why?
| | Apoptosis | 2 | 2009 | 2430 | 0.020 |
Why?
| | Postoperative Care | 1 | 2010 | 288 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2009 | 2609 | 0.020 |
Why?
| | Acute Disease | 1 | 2010 | 1031 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1268 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 455 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 389 | 0.020 |
Why?
| | Reoperation | 1 | 2010 | 631 | 0.020 |
Why?
| | Glycation End Products, Advanced | 1 | 2006 | 82 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2009 | 499 | 0.010 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2006 | 139 | 0.010 |
Why?
| | Transcription Factor AP-1 | 1 | 2004 | 79 | 0.010 |
Why?
| | Acetaminophen | 1 | 2006 | 264 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 4155 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 7183 | 0.010 |
Why?
| | Hepatectomy | 1 | 2005 | 273 | 0.010 |
Why?
| | Cell Death | 1 | 2004 | 383 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2004 | 699 | 0.010 |
Why?
| | Homeostasis | 1 | 2004 | 640 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2005 | 2185 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2010 | 2920 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2005 | 2499 | 0.010 |
Why?
| | Risk Factors | 1 | 2010 | 10792 | 0.010 |
Why?
|
|
Dun's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|